Formulations of pimavanserin | Patent Publication Number 20190216791

US 20190216791 A1

Patent NumberUS 10449185 B2

Application Number16363378

Filled DateMar 25, 2019

Priority Date-

Publication DateJul 18, 2019

Original AssigneeAcadia Pharmaceuticals Inc.

Current AssigneeAcadia Pharmaceuticals Inc.

Inventor/ApplicantsRavi Tejwani
Emanuel Joseph Vizzotti
Stephen Edward Abele

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.